Refreshing results…
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
UploadRenal cell carcinoma: the population, real world, and cost-of-illness
Download from doi.orgMissing publications? Search for publications with a matching author name.